<DOC>
	<DOCNO>NCT01099592</DOCNO>
	<brief_summary>Depression frequently see cardiac patient . It show depression often negative impact course coronary disease . More recently , research demonstrate antidepressant use safely treat depressed coronary patient . Although majority patient improve substantially antidepressant treatment , significant proportion respond antidepressant . This project seek good understand depression improve equally well patient . Ultimately , hope improve treatment available people affect cardiac disease depression , help select best type treatment advance individual base personal history , biological characteristic .</brief_summary>
	<brief_title>Antidepressants Promote Recovery Cardiac Patients Suffering From Depression</brief_title>
	<detailed_description>In study 140 patient recent hospitalization acute coronary syndrome major depression receive 12 week treatment antidepressant citalopram regular clinical management visit mental health professional . The objective examine characteristic depress cardiac patient show improvement depression citalopram treatment . There evidence cause depression may different people cardiac disease individual heart problem , difference may least partially involved determine response antidepressant treatment . Inflammation , one body 's response development atherosclerosis ( harden artery blockage heart ) may particularly important produce depression cardiac patient . There may also change body 's metabolism tryptophan , protein involve make serotonin , level serotonin often low depression . Other factor think influence development depression include childhood experience personality factor . Heredity family history also seem play role people depression heart disease . Finally , patient experience sleep apnea , interruption breathe asleep , contribute cardiac disease depression .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>At least 18 year old Diagnostic Statical ManualRevision 4 ( DSMIV ) diagnosis current MDD base Structured Clinical Interview Depression ( SCID ) Duration major depressive disorder ( MDD ) least 4 week baseline Hospital discharge acute coronary syndrome 4 24 week prior baseline No coronary artery bypass ( CABG ) surgery since admission index event , plan CABG next 4 month baseline Stable coronary artery disease ( CAD ) base physician 's clinical judgement Provision inform consent Exclusion Criteria Significant cognitive problem ( Minimental Status Exam , MMSE &lt; 24 ) Structured Clinical Interview Depression ( SCID ) document bipolar disorder use lithium anticonvulsant ( e.g . tegretol , depakene , neurontin ) mood disorder MINI International Neuropsychiatric Interview ( MINI ) document major depression psychotic feature MINI document current recent ( within 12 month ) substance abuse dependence Serious suicide risk base clinical judgment Currently take antidepressant ( include St. John 's Wort ) Absence response previous adequate trial citalopram Lifetime evidence citalopram intolerance lifetime evidence intolerance two SSRIs 2 previous unsuccessful trial treatment current depressive episode Depression due general medical condition base clinical judgment ( e.g. , clinical hypothyroidism ) Cold , flu infection dental work ( include teeth clean ) 14 day baseline Use antibiotic steroid ( topical steroid ) 14 day baseline Participation randomize clinical trial Inability speak French English Investigator 's judgement patient unable/unwilling comply study regimen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>